Published in Trends Pharmacol Sci on February 01, 1989
Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Br J Pharmacol (1992) 1.02
Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol (1994) 0.99
Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1994) 0.96
The crystal structure of the novobiocin biosynthetic enzyme NovP: the first representative structure for the TylF O-methyltransferase superfamily. J Mol Biol (2009) 0.88
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily. Eur J Clin Pharmacol (2009) 0.84
The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats. J Neural Transm (Vienna) (2004) 0.81
Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone. Br J Pharmacol (1996) 0.80
Parkinson's disease. Postgrad Med J (1995) 0.75
Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev (1999) 3.81
POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology (2004) 1.89
Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol (1995) 1.65
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry (1998) 1.60
Comparative liver toxicity of various erythromycin derivatives in animals. J Antimicrob Chemother (1988) 1.41
On the role of prolyl oligopeptidase in health and disease. Neuropeptides (2006) 1.39
Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother (1982) 1.32
Laminin is induced in astrocytes of adult brain by injury. EMBO J (1984) 1.28
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother (1983) 1.24
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors. J Med Chem (1989) 1.12
Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord (2003) 1.11
Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. Eur J Pharmacol (1988) 1.09
Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. Pharmacol Toxicol (1990) 1.04
Clinical and genetic findings in Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol (2000) 1.03
Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse. Br J Anaesth (1976) 0.97
Pharmacokinetics of nalidixinic acid and oxolinic acid in healthy women. Clin Pharmacol Ther (1976) 0.97
Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res (1997) 0.97
Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl (1995) 0.96
Effects of haloperidol on selective attention: a combined whole-head MEG and high-resolution EEG study. Neuropsychopharmacology (2001) 0.96
Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res (1992) 0.96
7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) (1997) 0.95
A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease. Br J Pharmacol (2012) 0.92
Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values. Med Hypotheses (2001) 0.91
Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone. Clin Pharmacol Ther (1990) 0.91
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner. Br J Pharmacol (2011) 0.91
General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. Gen Pharmacol (1994) 0.91
Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state. J Antimicrob Chemother (1988) 0.91
Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology (2000) 0.91
Suppression of transient 40-Hz auditory response by haloperidol suggests modulation of human selective attention by dopamine D2 receptors. Neurosci Lett (2000) 0.91
The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa. Acta Neurol Scand (1985) 0.90
How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry (2005) 0.89
Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase. Life Sci (1988) 0.88
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers. Clin Neuropharmacol (1995) 0.88
Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci (2000) 0.88
Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat. J Neural Transm (1987) 0.88
Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol (1984) 0.88
Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. Eur J Pharmacol (1999) 0.87
Catechol-O-methyltransferase activity in human and rat small intestine. Life Sci (1988) 0.87
Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience (2008) 0.87
Computerized rotometer apparatus for recording circling behavior. Methods Find Exp Clin Pharmacol (1989) 0.86
Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro. J Antimicrob Chemother (1988) 0.86
Clinical advantages of COMT inhibition with entacapone - a review. J Neural Transm (Vienna) (2004) 0.85
Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berl) (2001) 0.85
Tonsillar penetration of erythromycin and its 2'-acetyl ester in patients with chronic tonsillitis. J Antimicrob Chemother (1988) 0.84
Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice. Carcinogenesis (1986) 0.84
Effects of systemic carbidopa on dopamine synthesis in rat hypothalamus and striatum. J Neural Transm Park Dis Dement Sect (1992) 0.84
Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Clin Exp Immunol (2011) 0.84
Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat. Acta Endocrinol (Copenh) (1979) 0.84
Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease. Neuroimage (2001) 0.84
Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur J Pharmacol (1993) 0.83
Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo. Neuroscience (2011) 0.83
Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats. J Neural Transm Park Dis Dement Sect (1990) 0.83
Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother (1985) 0.83
Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers. Antimicrob Agents Chemother (1984) 0.83
Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study. Neuroscience (2008) 0.82
Scopolamine reduces the P35m and P60m deflections of the human somatosensory evoked magnetic fields. Neuroreport (2001) 0.81
Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.81
Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice. Br J Pharmacol (2009) 0.81
Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base. J Antimicrob Chemother (1988) 0.81
Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin. Neurosci Lett (1997) 0.81
Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases. Neuroscience (2013) 0.80
No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats. Eur J Pharmacol (1998) 0.80
Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease. J Pharmacol Exp Ther (1988) 0.80
Effects of aqueous extracts of Halimeda incrassata (Ellis) Lamouroux and Bryothamnion triquetrum (S.G.Gmelim) Howe on hydrogen peroxide and methyl mercury-induced oxidative stress in GT1-7 mouse hypothalamic immortalized cells. Phytomedicine (2003) 0.80
Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats. Pharmacol Toxicol (1999) 0.80
Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease. Mov Disord (1997) 0.79
Inhibitors of catechol-O-methyltransferase sensitize mice to pain. Br J Pharmacol (2010) 0.79
Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives. J Med Chem (1999) 0.79
Pharmacokinetics of clofibrate and chlorophenoxy isobutyric aicd. I. Cross-over studies on human volunteers. Acta Pharmacol Toxicol (Copenh) (1975) 0.79
Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. Clin Exp Immunol (2010) 0.79
L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats. Eur J Pharmacol (1998) 0.79
Different renal effects of two inhibitors of catechol-O-methylation in the rat: entacapone and CGP 28014. Acta Physiol Scand (1998) 0.79
Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation. Psychopharmacology (Berl) (1998) 0.78
N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur J Pharmacol (1994) 0.78
Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate. Antimicrob Agents Chemother (1988) 0.78
Intravenous cefuroxime prophylaxis. Tissue levels after one 3-gram dose in 40 cases of hip fracture. Acta Orthop Scand (1995) 0.78
Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats. Neuropeptides (1989) 0.78
Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze. Neuropeptides (1994) 0.78
Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur J Pharmacol (1993) 0.78
Studies on the site and mechanism of the inhibitory action of intracerebral histamine on the cold-stimulated thyrotropin secretion in male rats. Brain Res (1985) 0.78
Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations. J Psychiatry Neurosci (2000) 0.78
Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels. Eur Neuropsychopharmacol (1997) 0.78
Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol. Br J Pharmacol (1978) 0.78
Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport (1995) 0.78
Modification of GABAergic activity and thyrotropin secretion in male rats. Acta Pharmacol Toxicol (Copenh) (1980) 0.78
The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat. Pflugers Arch (2001) 0.78
Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection. Biomed Chromatogr (1989) 0.78
Further evidence of the dual role of noradrenaline in regulation of thyrotrophin secretion in male rats. Acta Endocrinol (Copenh) (1981) 0.78
Inhibition of the TSH secretion by histamine in male rats. Acta Endocrinol (Copenh) (1983) 0.78
Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat. Eur J Pharmacol (1981) 0.77
Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.77
Neurochemical and psychomotor interactions of new selective COMT inhibitors with clorgyline and nomifensine in levodopa-treated rats and mice. Arch Int Pharmacodyn Ther (1993) 0.77
Absorption of various erythromycin esters and salts in mice after intragastric intubation. Methods Find Exp Clin Pharmacol (1992) 0.77
Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Brain Res (1992) 0.77
Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation. Neuroreport (2001) 0.77